drug discovery

July 8, 2016July 8, 2016

Morphic Raises $51.5M to Develop Next-Generation Integrin Therapies for IBD, Other Diseases

Crohn's Disease, IBD News, News, Ulcerative colitis

Morphic Therapeutic announced that it has raised $51.5 million through Series A financing to advance products and bring them into clinical testing. The Massachusetts-based company specializes in oral integrins. SR One and Pfizer Venture Investments led ... Read more

December 15, 2015December 15, 2015

Collaborative Effort Leads to Potential New Class of Drugs for Crohn’s Disease and Other Autoimmune Disorders

News

A joint effort between researchers at Merck Research Laboratories (named MSD outside the U.S. and Canada), Eindhoven University of Technology (TU/e) and Leiden University, both in The Netherlands, has led ... Read more

July 28, 2015July 28, 2015

New Therapy Targeting microRNA-214 Blocks Ulcerative Colitis Disease Progression

News, Ulcerative colitis

Scientists at the UCLA Jonsson Comprehensive Cancer Center developed a new therapy that blocks progression of ulcerative colitis and colon cancer in mice. Together with Crohn’s disease, ulcerative colitis is ... Read more